GLI2 and hepatocellular carcinoma: In summary, the SHH signaling pathway (including SHH, PTCH-1, SMO, and GLI-1) and GLI-2 (driven by TGF-β 1/SMASD 3 signaling) affect the recurrence and metastasis of HCC.